Researchers are excited about new treatments for hepatitis
Researchers are excited about new treatments for hepatitis...especially the chronic, active forms of hepatitis B and C.
Antivirals are being tried...ribavirin for chronic hepatitis C and the new HIV drug, lamivudine (3TC), for chronic hepatitis B.
But no antivirals are approved for hepatitis...because their clinical benefit hasn't been shown. The ribavirin being studied for hepatitis is an ORAL form...not the aerosol version used for RSV.